PIRS

Pieris Pharmaceuticals (PIRS)

Pieris Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PIRS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/16	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2024/05/09	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2024/02/15	06 : 37	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2024/02/15	03 : 12	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2024/02/14	23 : 19	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2024/02/02	23 : 59	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/12/22	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/11/15	06 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/09/01	05 : 15	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/08/11	06 : 04	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/08/11	05 : 24	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/07/18	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/07/13	20 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/27	06 : 26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/24	05 : 47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/24	05 : 47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/24	05 : 47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/24	05 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/24	05 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/21	20 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/12	19 : 43	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/08	19 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/05/31	05 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/05/23	06 : 01	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/05/20	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/05/11	19 : 02	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/05/10	20 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/04/29	05 : 22	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/04/29	05 : 20	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/04/01	05 : 05	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc